Slone Partners

About Us

With a dedicated focus on the life sciences and healthcare industries, Slone Partners is a premier executive search and talent advisory firm with more than 25 years of success delivering visionary leaders and fractional talent who build and scale amazing organizations. With a nationwide presence and global reach, we specialize in discovering and placing innovative leaders, including world-class Board, C-Suite, and upper management professionals.

 

ACHIEVEMENTS

Recent Placements

Slone Partners

Leadership

6

Our leadership is deeply embedded in the industry and supported by an Advisory Board of experts from every sector that we serve.

Staying at the cutting edge of every change in the market allows us to deliver the right candidates for your business and provide invaluable counsel no matter how unique your needs.

Slone Partners

Solutions And Expertise

Founded in 2000, Slone Partners is a premier executive search firm that specializes in recruitment for companies focused in biotechnology, pharma services, life science tools, diagnostics, genomics, clinical services, medical devices, data and analytics, and food sciences.

Solutions
  • Board/Director Search
  • Executive Recruitment
  • Executive Search
  • Fractional
  • Fractional and Interim Services
  • Fractional Executive
  • On-Demand Recruiting
  • On-Demand Talent Solutions
  • Professional Search
Industries
  • Biotechnology
  • Executive Search
  • Healthcare
  • Healthcare Services
  • Healthtech
  • Hospital Foundations
  • Life Sciences
  • Life Sci./Healthcare
  • Medical Devices
  • Pharmaceuticals
  • Science and Research
Functions
  • Board Members
  • Board of Directors
  • Business Leaders
  • C-Level
  • C-Level Leaders
  • C-Suite
  • Clinical Directors
  • Clinical Operations
  • Director/VP
  • General Counsel
  • Head of Department
  • Healthcare
  • Healthcare Board Placements
  • President
  • SVP
  • Vice President

Slone Partners

News Briefings

How DEI is Impacting How We Recruit and Retain Talent

Until recent years, executive recruiters would often speak about sourcing candidates who seem to be a good “culture fit” for an organization. The idea behind it was that potential hires who were aligned with the look and feel of the existing culture would easily assimilate into it, and would require less time to ramp up

Slone Partners Expands Search Team

Life sciences-focused search firm Slone Partners has expanded with the addition of Kate Portland as vice president of client partnerships. “Kate Portland is an accomplished and highly respected executive talent recruiter and client development specialist with an impressive track record of success over more than 20 years,” said Leslie Loveless, CEO. “With her vast experience formulating and executing high-level

As Investors Retreat, Healthcare/Life Sciences Sector Stays Resilient

Healthcare and life science organizations are facing an increasingly complex landscape, with rapid technological advancements, changing regulatory environments, and heightened public scrutiny. As a result, these companies have been turning to executive search firms more than ever to land world-class leadership. The most pressing challenge has been finding high-impact, innovative leaders who can navigate this

Slone Partners Recruits CEO for ONI

Life sciences-focused search firm Slone Partners has recruited Paul Scagnetti as CEO of biotechnology company ONI. He succeeds founding CEO Bo Jing, who will remain with ONI as a key contributor in product development to help inspire ONI’s next innovations. “Paul Scagnetti is a tremendously experienced, driven, passionate business leader and visionary with both the strategic and tactical

Slone Partners

Press Releases

Slone Partners Places John Russell as Executive Chairman at Ultromics

SOUTH RIDING, VA. – March 15, 2023 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of John Russell as Executive Chairman at Ultromics, a global pioneering health technology company focused on reducing the global burden of heart failure. Russell is a well-respected leader in the medical device and diagnostic sectors

Slone Partners Places Paul Scagnetti as Chief Executive Officer at ONI

SOUTH RIDING, VA. – March 14, 2023 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Paul Scagnetti as Chief Executive Officer (CEO) at ONI, the biotechnology company broadly enabling the ability to observe single molecules in living cells with its desktop Nanoimager microscopy platform. As CEO, Scagnetti will be

Slone Partners Expands its Board Placement Service Line for Companies in Life Sciences, Healthcare, Cybersecurity, and Beyond

Expanded line reflects Slone Partners’ focus on delivering the most diverse and qualified Board members for amazing organizations SOUTH RIDING, VA. – March 9, 2023 – Slone Partners, a nationwide executive search firm for life sciences and healthcare companies, has announced that it will expand its line of executive Board placement services to serve more companies in life

Slone Partners Places Gayathri Swaminath as SVP of Discovery and Edward Moler as VP of Data Science at Juvena Therapeutics

SOUTH RIDING, VA. – February 9, 2023 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Edward Moler, PhD as Vice President of Data Science and Gayathri Swaminath, PhD, MBA as Senior Vice President of Discovery at Juvena Therapeutics, a biotechnology company scaling a computational platform to map the therapeutic potential

Slone Partners Places Amy Levin as Vice President of Regulatory Affairs at Mainz Biomed

SOUTH RIDING, VA. – January 19, 2023 – Slone Partners, a nationwide executive search firm for life sciences, biotechnology, and healthcare companies, has announced the placement of Amy Levin as Vice President of Regulatory Affairs at Mainz Biomed, a biomedical company that develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. In her new role, Levin will be charged with